Assessment of molecular tools in pediatric, adolescent, and young adult meningioma highlights the need for lifespan precision in neuro-oncology

Molecular tools developed in adult-dominant cohorts do not generalize to younger patients due to both biological divergence and exclusion from model development. These findings underscore the need for age-specific molecular frameworks and highlight the imperative of including P/AYA populations in precision neuro-oncology research to ensure lifespan-equitable care.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2025-11-06
DOI
https://doi.org/10.1093/neuonc/noaf252
Primary Topic
Meningioma and schwannoma management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Assessment of molecular tools in pediatric, adolescent, and young adult meningioma highlights the need for lifespan precision in neuro-oncology

Jeff Liu, Farshad Nassiri, Kenneth Aldape, Aaron Cohen‐Gadol et al.
Neuro-Oncology
Meningioma and schwannoma management
article

Assessment of molecular tools in pediatric, adolescent, and young adult meningioma highlights the need for lifespan precision in neuro-oncology

Jeff Liu, Farshad Nassiri, Kenneth Aldape, Aaron Cohen‐Gadol, Marcos Tatagiba, Olivia Singh, Severa Bunda, Felix Behling, Chloe Gui, Silky Chotai, Leeor Yefet, Derek S. Tsang, Jill S. Barnholtz‐Sloan, Alireza Mansouri, Serge Makarenko, Andrew Ajisebutu, Justin Z. Wang, Sameer Agnihotri, Yasin Mamatjan, Yosef Ellenbogen, Ramneet Kaloti, Gelareh Mohammed Zadeh, Qingxia Wei, Lola B. Chambless, Andrew Edward Sloan, Sheila Mansouri, Ghazaleh Tabatabai, Andrew Gao, Alexander Landry, Vikas Patil, Stephen Yip, Rebecca Yakubov, Phooja Persaud
article en

Abstract

Molecular tools developed in adult-dominant cohorts do not generalize to younger patients due to both biological divergence and exclusion from model development. These findings underscore the need for age-specific molecular frameworks and highlight the imperative of including P/AYA populations in precision neuro-oncology research to ensure lifespan-equitable care.

Neuro-Oncology
University Health Network (CA), Mayo Clinic (US), University of British Columbia (CA), Thompson Rivers University (CA), University of Pittsburgh (US), University of Toronto (CA), Keck Hospital of USC (US), Princess Margaret Cancer Centre (CA), Piedmont Cancer Institute (US), National Cancer Institute (UA), University Children's Hospital Tübingen (DE), Bernstein Center for Computational Neuroscience Tübingen (DE), National Cancer Institute (US), Hertie Institute for Clinical Brain Research (DE), Mayo Clinic in Florida (US), Center for Cancer Research (US), Neurological Surgery (US), Division of Cancer Epidemiology and Genetics, University of Tübingen (DE), Penn State Milton S. Hershey Medical Center (US), Vanderbilt University Medical Center (US)
Openalex Percentile: Top 56%
Meningioma and schwannoma management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.